Subscribe to RSS
DOI: 10.1055/s-2008-1042915
A Novel and Versatile Access to Task-Specific Ionic Liquids Based on 1,2,3-Triazolium Salts
Publication History
Publication Date:
17 March 2008 (online)
Abstract
Novel task-specific ionic liquids based on 1,2,3-triazolium salts were prepared in a straightforward two-step procedure. Azides and alkynes were transformed into 1,4-disubstituted 1,2,3-triazoles by Cu-catalyzed click reaction. Subsequent alkylation afforded 1,3,4-trisubstituted 1,2,3-triazoles as ionic liquids. Useful functionalities, such as organocatalysts, fluorophors or linkers can be incorporated into the ionic liquids in this way.
Key words
ionic liquids - alkylation - heterocycles - click reaction - 1,2,3-triazolium salts
- 1
Wasserscheid P.Welton T. Ionic Liquids in Synthesis 2nd ed., Vol. 1: Wiley-VCH; Weinheim: 2008. - 2
Earle MJ.Seddon KR. Pure Appl. Chem. 2000, 72: 1391 - 3
Wasserscheid P.Welton T. Ionic Liquids in Synthesis 2nd ed., Vol. 2: Wiley-VCH; Weinheim: 2008. - 4
Jain N.Kumar A.Chauhan S.Chauhan SMS. Tetrahedron 2005, 61: 1015 - 5
Davis JH. Synthesis of Task-Specific Ionic Liquids Wiley-VCH; Weinheim: 2003. - 6
Vaultier M.Kirschning A.Singh V. Task-Specific Ionic Liquids as New Phases for Supported Organic Synthesis Wiley-VCH; Weinheim: 2007. - 7
Luo SZ.Mi XL.Zhang L.Liu S.Xu H.Cheng JP. Angew. Chem. Int. Ed. 2006, 45: 3093 - 8
Tornoe CW.Christensen C.Meldal M. J. Org. Chem. 2002, 67: 3057 - 9
Rostovtsev VV.Green LG.Fokin VV.Sharpless KB. Angew. Chem. Int. Ed. 2002, 41: 2596 - 10
Cheng LJ.Chen Q.Liu J.Du YG. Carbohydr. Res. 2007, 342: 975 -
11a
Gil MV.Arevalo MJ.Lopez O. Synthesis 2007, 1589 -
11b
Zeitler K.Mager I. Adv. Synth. Catal. 2007, 349: 1851 - 12
Geci I.Filichev VV.Pedersen EB. Chem. Eur. J. 2007, 13: 6379 - 13
Lenda F.Guenoun F.Martinez J.Lamaty F. Tetrahedron Lett. 2007, 48: 805 - 14
Castagnolo D.Dessi F.Radi M.Botta M. Tetrahedron: Asymmetry 2007, 18: 1345 - 15
Gompper R. Chem. Ber. 1957, 90: 382 - 16
Wamhoff H. 1,2,3-Triazoles and their Benzo Derivatives Pergamon Press; Oxford / New York / Sydney: 1984. - 17
Begtrup M. Acta Chem. Scand. 1971, 25: 249 - 18
Kaplan G.Drake G.Tollison K.Hall L.Hawkins T. J. Heterocycl. Chem. 2005, 42: 19 - 19
Drake G.Kaplan G.Hall L.Hawkins T.Larue J. J. Chem. Cryst. 2007, 37: 15 - 21
Fazio F.Bryan MC.Blixt O.Paulson JC.Wong CH. J. Am. Chem. Soc. 2002, 124: 14397
References and Notes
Preparation of 3; General Procedure: The azide 1 (20 mmol) was dissolved in the appropriate solvent (50 mL) and CuI (see Table
[1]
) was added. The flask was flushed with argon and the mixture was kept under argon until the workup procedure (balloon) was followed. DIPEA (see Table
[1]
) and the alkyne 2 (10 mmol) were added one after the other, the latter in portions under stirring. If the alkyne was a solid or a sticky liquid, the solvent quantity of 50 mL was shared for dissolving the azide and the alkyne. After a short time an exothermic reaction started and the pace of the addition of the alkyne was adjusted accordingly. Cooling by a water-bath might be advisable. After complete addition of the alkyne stirring was continued at r.t. The mixture was diluted with CHCl3 (50 mL) and filtered. The filtrate was evaporated and the residue was purified by column chromatography (Kieselgel 60; MeOH-CHCl3, 1:19). If DMF was used as solvent, the reaction mixture was diluted with CHCl3 (250 mL), filtered and the filtrate was washed with H2O (3 × 150 mL) and dried with Na2SO4 before volatile compounds were removed under vacuum. Eventually the washing procedure had to be repeated.
Preparation of 5; General Procedure: A solution of the 1,2,3-triazole 3 (20 mL) and the alkylating reagent 4 (see Table
[1]
) in anhyd MeCN (30 mL) was refluxed (see Table
[1]
). All volatile compounds were removed under vacuum with a rotary evaporator leaving behind the ionic liquid as an oil or a sticky oil.
Compound 3a: 1H NMR (300.13 MHz, CDCl3): δ = 0.87 (t, J = 7.2 Hz, 3 H, CH2CH2CH2CH
3), 1.32 (sext, J = 7.4 Hz, 2 H, CH2CH2CH
2CH3), 1.58 (m, 2 H, CH2CH
2CH2CH3), 2.68 (t, J = 7.8 Hz, 2 H, CH
2CH2CH2CH3), 5.46 (s, 2 H, CH
2NNN), 7.19 (s, 1 H, CH), 7.27 (m, 5 H, Ph). 13C NMR (75.47 MHz, CDCl3): δ = 13.7 (CH2CH2CH2
CH3), 22.1 (CH2CH2
CH2CH3), 25.3 (CH2
CH2CH2CH3), 31.3 (CH2CH2CH2CH3), 53.8 (PhCH2), 120.5 (CHtriazole), 127.8 (CH
o
), 128.4 (CH
m
), 128.9 (CH
p
), 134.8 (CPh), 148.8 (Ctriazole).
Compound 3e: [α]D
25 -80.3 (c 0.02, CHCl3). 1H NMR (300.13 MHz, CDCl3): δ = 1.96 (m, 4 H, NCbzCHCH
2CH
2), 3.48 (m, 2 H, NCbzCH2), 4.30 (m, 1 H, NCbzCH), 5.00 (m, 2 H, PhCH2NNN), 5.17 (m, 2 H, COOCH2), 5.34 (s, 1 H, NCOOCH
2Ph), 5.42 (s, 1 H, NCOOCH
2Ph), 7.23 (m, 10 H, 2 × Ph), 7.56 (s, 1 H, CHtriazole). 13C NMR (75.47 MHz, CDCl3): δ = 23.5 (NCbzCH2
CH2), 30.0 (NCbzCHCH2), 46.4 (NCbzCH2), 53.7 (PhCH2NNN), 57.9 (COOCH2), 58.7 (NCbzCH), 66.5 (PhCH2OCON), 123.3 (CHtriazole), 127.2-128.7 (CHPh), 134.2 (NNNCH2
C), 136.3 (NCOOCH2
C), 142.6 (CHCOOCH2
C), 154.2 (NCOOCH2Ph), 172.2 (CHCOOCH2).
Compound 3g: [α]D
25 -260.7 (c 0.033, CHCl3). H NMR (300.13 MHz, CDCl3): δ = 0.83 (t, J = 6.5 Hz, 3 H, CH2CH2CH2CH2CH
3), 1.27 (m, 5 H, CH2CH2CH
2CH
2CH3 + NCbzCHCHH), 1.61 (m, 3 H, NCbzCHCHHCH
2), 1.89 (m, 2 H, CH2CH
2CH2CH2CH3), 2.60 (m, 2 H, CH
2CH2CH2CH2CH3), 3.15 (m, 1 H, NCbzCHH), 3.33 (m, 1 H, NCbzCHH), 4.10 (m, 1 H, NCbzCH), 4.48 (m, 2 H, CHCH
2NNN), 5.13 (m, 2 H, PhCH
2), 6.88 (s, 0.7 H, CH
triazole), 7.10 (s, 0.3 H, CH
triazole), 7.31 (m, 5 H, Ph).
13C NMR (75.47 MHz, CDCl3): δ = 13.8 (CH2CH2CH2CH2
CH3), 22.2 (CH2CH2CH2
CH2CH3), 23.1 (NCbzCHCHH), 25.3 (CH2CH2CH2CH2CH3), 27.8 (CH2
CH2CH2CH2CH3), 28.9 (NCbzCHCH2
CH2), 31.1 (CH2CH2
CH2CH2CH3), 46.8 (NCbzCH2), 51.5 (CH2NNN), 57.1 (CHCH2NNN), 66.9 (PhCH2), 121.2 (CHtriazole), 127.7-128.4 (CHPh), 136.3 (CPh), 148.3 (Ctriazole), 154.5 (NCOO).
Compound 5a: 1H NMR (400.13 MHz, CD3CN): δ = 0.92 (t, J = 7.6 Hz, 3 H, CH2CH2CH2CH
3), 1.40 (sext, J = 7.4 Hz, 2 H, CH2CH2CH
2CH3), 1.65 (m, 2 H, CH2CH
2CH2CH3), 2.81 (t, J = 7.2 Hz, 2 H, CH
2CH2CH2CH3), 4.12 (s, 3 H, N+Me), 5.82 (s, 2 H, CH2NNN), 7.46 (m, 5 H, Ph), 8.70 (s, 1 H, CH). Signals at δ = 2.81 and 4.12 ppm showed a weak cross peak with each other in the NOESY spectrum. 13C NMR (100.61 MHz, CD3CN): δ = 13.5 (CH2CH2CH2
CH3), 22.2 (CH2CH2
CH2CH3), 23.4 (CH2
CH2CH2CH3), 29.0 (CH2CH2CH2CH3), 38.5 (N+Me), 57.1 (PhCH2), 117.9 (CHtriazole), 128.8 (CH
o
), 129.6 (CH
m
), 130.0 (CH
p
), 133.0 (CPh), 145.5 (Ctriazole).
Compound 5e: [α]D
25 -36.1 (c 0.024, CHCl3). 1H NMR (300.13 MHz, CDCl3): δ = 1.87 (m, 4 H, NCbzCHCH
2CH
2), 3.40 (m, 2 H, NCbzCH2), 4.06 (s, 3 H, N+Me), 4.21 (m, 1 H, NCbzCH), 4.89 (m, 2 H, PhCH2NNN), 5.45 (m, 2 H, COOCH2), 5.34 (s, 1 H, NCOOCH2Ph), 5.42 (s, 1 H, NCOOCH2Ph), 7.27 (m, 10 H, 2 × Ph), 8.87 (s, 1 H, CHtriazole). 13C NMR (75.47 MHz, CDCl3): δ = 23.1 (NCbzCH2
CH2), 29.9 (NCbzCHCH2), 39.3 (N+Me), 46.3 (NCbzCH2), 54.2 (PhCH2NNN), 57.0 (COOCH2), 58.6 (NCbzCH), 66.5 (PhCH2OCON), 123.3 (CHtriazole), 127.0-130.6 (CHPh), 135.9 (NNNCH2
C), 138.3 (NCOOCH2
C), 142.3 (CHCOOCH2
C), 153.9 (NCOOCH2Ph), 171.5 (CHCOOCH2).
Compound 5g: [α]D
25 -72.9 (c 0.02, CHCl3). 1H NMR (300.13 MHz, CD3CN): δ = 0.87 (t, J = 6.5 Hz, 3 H, CH2CH2CH2CH2CH
3), 1.31 (m, 5 H, CH2CH2CH
2CH
2CH3 + NCbzCHCHH), 1.58 (m, 3 H, NCbzCHCHHCH
2), 1.87 (m, 2 H, CH2CH
2CH2CH2CH3), 2.39 (m, 2 H, CH
2CH2CH2CH2CH3), 3.16 (m, 1 H, NCbzCHH), 3.34 (m, 1 H, NCbzCHH), 3.90 (m, 1 H, NCbzCH), 4.07 (s, 3 H, N+Me), 4.51 (m, 2 H, CHCH
2NNN), 5.12 (m, 2 H, PhCH
2), 7.35 (m, 5 H, Ph), 8.55 (s, 1 H, CHtriazole). 13C NMR (75.47 MHz, CD3CN): δ = 14.0 (CH2CH2CH2CH2
CH3), 22.6 (CH2CH2CH2
CH2CH3), 23.5 (NCbzCHCHH), 25.7 (CH2CH2CH2CH2CH3), 27.1 (CH2
CH2CH2CH2CH3), 28.6 (NCbzCHCH2
CH2), 31.2 (CH2CH2
CH2CH2CH3), 38.3 (N+Me), 47.3 (NCbzCH2), 51.6 (CH2NNN), 57.6 (CHCH2NNN), 67.0 (PhCH2), 118.1 (CHtriazole), 128.1-129.7 (CHPh), 137.8 (CPh), 146.8 (Ctriazole), 155.6 (NCOO).